Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

DuchenneConnect Direct Access Webinar: Dr. Kathryn Wagner

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
589 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Sep 29, 2011

DuchenneConnect presents a webinar series that allows you direct access to key figures in the fight to end Duchenne.

The first installment in our series features Dr. Kathryn Wagner, Director of the Center for Genetic Muscle Disorders of The Kennedy Krieger Institute and John Hopkins School of Medicine.

Kathryn Wagner, MD, PhD leads the Kennedy Krieger Institute's (KKI) interdisciplinary clinic. Because young men with Duchenne often find it difficult to transition services from pediatric to adult, the model for the KKI neuromuscular clinic includes transition. Kathryn's team is currently recruiting young adults and adults for a clinical trial with Revatio (also known as Sildenafil) for heart disease in Duchenne and Becker muscular dystrophy.

Watch to learn more about Kennedy Krieger Institute's interdisciplinary clinic, transition services, clinical trials, and future plans.

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more